Home LiteratureArticle Details
PMID: 12958210 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.

Cyr M, Beaulieu JM, Laakso A, Sotnikova TD, Yao WD, Bohn LM, Gainetdinov RR, Caron MG

Abstract

Dopamine is believed to contribute to the degeneration of dopamine-containing neurons in the brain. However, whether dopamine affects the survival of other neuronal populations has remained unclear. Here we document that mice with persistently elevated extracellular dopamine, resulting from inactivation of the dopamine transporter gene, sporadically develop severe symptoms of dyskinesia concomitant with apoptotic death of striatal dopamine-responsive gamma-aminobutyric acidergic neurons. Chronic inhibition of dopamine synthesis prevents the appearance of motor dysfunction. The neuronal death is associated with overactivation of dopaminergic signaling as evidenced by the robust up-regulation of striatal DeltaFosB, cyclin-dependent kinase 5, and p35. Moreover, hyperphosphorylation of the tau protein, a phenomenon associated with the activation of cyclin-dependent kinase 5 in several neurodegenerative disorders, is observed in symptomatic mice. These findings provide in vivo evidence that, in addition to its proposed role in the degeneration of dopamine neurons, dopamine can also contribute to the selective death of its target neurons via a previously unappreciated mechanism.

MeSH Terms
Animals Apoptosis Blotting, Western Corpus Striatum/metabolism,pathology Dopamine/metabolism Mice Mice, Inbred C57BL Mice, Knockout Neurons/cytology,metabolism Phosphorylation Signal Transduction gamma-Aminobutyric Acid/metabolism
Chemicals
gamma-Aminobutyric Acid Dopamine
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Cyr Michel
Howard Hughes Medical Institute Laboratory, Department of Cell Biology, and Center for Models of Human Disease, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA.
Beaulieu Jean-Martin
Laakso Aki
Sotnikova Tatyana D
Yao Wei-Dong
Bohn Laura M
Gainetdinov Raul R
Caron Marc G
References (40)
40 references, click to expand
  1. Neurodegenerative tauopathies.
    Annu Rev Neurosci. 2001;24:1121-59 PMID: 11520930
  2. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
    Neuron. 2001 Apr;30(1):135-47 PMID: 11343650
  3. Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
    Biol Psychiatry. 2001 Nov 15;50(10):813-6 PMID: 11720701
  4. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Neurology. 2002 Feb 26;58(4):589-92 PMID: 11865137
  5. D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons.
    J Neurosci. 2002 Jul 15;22(14):6092-105 PMID: 12122070
  6. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.
    J Neurosci. 2002 Oct 15;22(20):8951-60 PMID: 12388602
  7. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.
    J Neurosci. 2002 Nov 15;22(22):9733-41 PMID: 12427828
  8. Monoamine transporters: from genes to behavior.
    Annu Rev Pharmacol Toxicol. 2003;43:261-84 PMID: 12359863
  9. Loss of striatal neurons in Parkinson's disease: a cytometric study.
    Eur Neurol. 1980;19(5):339-44 PMID: 7398694
  10. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.
    J Neurosci. 1984 Jan;4(1):111-24 PMID: 6319625
  11. Substantia nigra lesion protects against ischemic damage in the striatum.
    Neurosci Lett. 1987 Oct 5;80(3):251-6 PMID: 3120058
  12. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease.
    Brain Res. 1988 Jul 5;455(1):148-52 PMID: 3416180
  13. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Neurosci Lett. 1989 Dec 15;107(1-3):256-60 PMID: 2515501
  14. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
    Cell. 1995 Sep 22;82(6):937-48 PMID: 7553854
  15. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Nature. 1996 Feb 15;379(6566):606-12 PMID: 8628395
  16. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1956-61 PMID: 8700866
  17. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum.
    J Comp Neurol. 1996 Oct 7;374(1):70-83 PMID: 8891947
  18. Neurotoxicity of amphetamines and their metabolites.
    NIDA Res Monogr. 1997;173:128-45 PMID: 9260187
  19. Reactive astrocytes: cellular and molecular cues to biological function.
    Trends Neurosci. 1997 Dec;20(12):570-7 PMID: 9416670
  20. Profound neuronal plasticity in response to inactivation of the dopamine transporter.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34 PMID: 9520487
  21. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor.
    J Neurochem. 1998 Jun;70(6):2406-15 PMID: 9603205
  22. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    J Neurosci. 1998 Jul 1;18(13):4861-9 PMID: 9634552
  23. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis.
    Brain Res Brain Res Rev. 1998 May;26(2-3):148-53 PMID: 9651511
  24. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.
    Nat Genet. 1998 Oct;20(2):198-202 PMID: 9771716
  25. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    J Neurosci. 1998 Dec 1;18(23):10116-27 PMID: 9822765
  26. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
    Science. 1999 Jan 15;283(5400):397-401 PMID: 9888856
  27. Choreoathetoid movements in cocaine dependence.
    Biol Psychiatry. 1999 Jun 15;45(12):1630-5 PMID: 10376125
  28. DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity.
    Brain Res. 1999 Jul 17;835(1):10-7 PMID: 10448191
  29. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
    Eur J Neurosci. 1999 Oct;11(10):3499-511 PMID: 10564358
  30. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Nature. 1999 Dec 9;402(6762):615-22 PMID: 10604467
  31. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
    Cell. 2000 Mar 31;101(1):57-66 PMID: 10778856
  32. Neuronal cell death in Huntington's disease: a potential role for dopamine.
    Trends Neurosci. 2000 Jun;23(6):239-45 PMID: 10838590
  33. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6809-14 PMID: 10829080
  34. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences.
    Eur J Neurosci. 2000 Aug;12(8):2985-92 PMID: 10971639
  35. Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
    Trends Neurosci. 2000 Oct;23(10 Suppl):S92-100 PMID: 11052226
  36. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex.
    Biol Psychiatry. 2001 Jan 1;49(1):1-12 PMID: 11163774
  37. Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.
    Neurobiol Dis. 2001 Feb;8(1):32-44 PMID: 11162238
  38. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.
    Nature. 2001 Mar 15;410(6826):376-80 PMID: 11268215
  39. Cocaine-induced persistent dyskinesias.
    Neurology. 2001 Apr 10;56(7):964-5 PMID: 11294937
  40. A decade of CDK5.
    Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59 PMID: 11584302
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-09-16
Epub
2003-00-04
Pages
11035-40
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC196922
Subset
IM
Grants
NIDA NIH HHS · K01 DA014600 · United States
NINDS NIH HHS · R01 NS019576 · United States
NIDA NIH HHS · K01 DA14600 · United States
NINDS NIH HHS · NS19576 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com